Ingredient review —Calcium
What is it?
Description
Calcium is an essential mineral that is commonly used to promote healthy bones and teeth. It is often found in dairy products, though various nuts, seeds, leafy greens, and cruciferous vegetables also contain calcium. Daily requirements for calcium vary by age and whether or not the individual is pregnant or lactating. Most guidelines indicate that individuals older than 19 years of age require between 1,000 to 1,300 mg per day. (37) In infants (0 to 12 months), the National Institute of Health recommends 200 to 260 mg as an adequate intake, whereas the recommended dietary allowance (RDA) rises to 700 mg and 1,000 mg in children 1 to 3 and 4 to 8 years of age, respectively. Older children and adolescents (ages 9 to 18) are recommended to consume 1,300 mg per day. (108)
In healthy individuals, approximately 99% of calcium is stored in bone, while circulating blood levels are maintained between 8.8 to 10.4 mg/dL (2.2–2.6 mmol/L). (142) The homeostatic-monitoring of calcium levels acts to regulate brain, cardiovascular, hormonal, muscular, nerve, and skeletal functions, (96)(163) and ensures that the intake of calcium from the diet or from supplements produces little variability in circulating levels. (135) However, calcium supplementation may be indicated in populations at risk for hypocalcemia due to low or non-existent intake from the diet or for individuals taking certain medications. Considering average intakes in Western countries are under the RDA at approximately 700 to 800 mg per day, (147) a proportion of the population may safely benefit from supplementation if increased dietary intake is unrealistic. In general, long-term supplementation of up to 500 mg per day of calcium may be most effectively and safely used with a meal, in combination with vitamin D, and when the dietary intake of calcium does not exceed 800 mg per day. (26) Higher divided doses may be required if intake is still below the recommended levels.
Please note that while calcium is often combined with other ingredients such as vitamin D or magnesium, this review will only detail evidence for the use of calcium supplementation on its own. It should be noted that a significant amount of evidence (e.g., calcium plus vitamin D in the treatment of osteoporosis) is omitted from this ingredient review.
Main uses
Blood pressure regulation
Bone health
Hypocalcemia and hyperphosphatemia regulation
Prenatal health
Formulations
Formulation
Characteristics
Calcium carbonate
Contains 40% elemental calcium
Most commonly used form, and regularly used in research
Least expensive, but requires stomach acid to be properly absorbed; should be taken with a meal to reduce the likelihood of adverse GI events (68)(144)(163)
It is unclear whether calcium carbonate provides better, (85) lesser, (86) or equivalent (20) effects on the suppression of bone resorption markers than calcium citrate when taken with a meal, but it does appear to be less effective when taken on an empty stomach (at bedtime) than calcium citrate-malate. (44)
Calcium citrate
Contains 21% elemental calcium
Commonly used form and regularly used in research
More expensive than calcium carbonate, but does not need to be taken with a meal; should be used in people using H2 blockers or proton pump inhibitors, or in individuals with achlorhydria (144)(163)
Calcium lysinate
Contains 30% elemental calcium
Provides greater bioavailability than calcium carbonate or calcium citrate-malate (138)
Calcium chloride
Calcium fumarate
Contains 26% elemental calcium
Provides equal bioavailability to calcium gluconate (110)
Calcium acetate
Calcium hydroxyapatite (microcrystalline hydroxyapatite complex, MCHC; ossein-hydroxyapatite complex, OHC)
Contains 21% elemental calcium; derived from animal bone and is therefore not appropriate for vegetarians or vegans
A complex containing calcium, phosphorus, and bone metabolism proteins including osteocalcin, type I collagen, insulin growth factor type I and II, & transforming growth factor-ꞵ (TGFꞵ).
A meta-analysis shows that calcium hydroxyapatite users had 1.02% higher BMD (mainly via an attenuation of bone loss) than calcium carbonate. (30)
Comparative studies published since the release of the above meta-analysis have continued to support this relationship, with a similar if not slightly better (~5% difference) adverse effect profile; (29)(36) calcium hydroxyapatite may provide a greater analgesic effect in osteopenia than calcium carbonate. (31)
Calcium hydroxyapatite increased serum calcium to a lesser extent than calcium carbonate or citrate, but produced greater phosphate and calcium-phosphate concentrations. However, it also resulted in equivalent reductions in bone resorption markers and bone turnover. (20) Calcium citrate, carbonate, pidolate, and gluconolactate reduced PTH to a greater extent than calcium hydroxyapatite. (46)
Calcium hydroxyapatite provided similar benefits to bone turnover (statistically equivalent) as tricalcium phosphate, but may provide a small clinical advantage for BMD over tricalcium phosphate. (1)
Calcium pidolate
Calcium lactate
Contains 13% elemental calcium
Provides similar bioavailability to calcium carbonate, calcium citrate, calcium gluconate, calcium lactate, and calcium acetate in a fasted state (139)
Calcium lactate gluconate
Contains 12% elemental calcium
Provides similar bioavailability to calcium carbonate, citrate, and pidolate, but lower PTH suppression than carbonate and citrate in a fasted state (46)
Calcium citrate-malate
Calcium gluconate
Other forms without comparative evidence
Calcium phosphate: contains 38% elemental calcium
Calcium aspartate: contains 23% elemental calcium
Calcium malate: contains 23% elemental calcium
Calcium glycinate: contains 21% elemental calcium
Calcium butyrate: contains 19% elemental calcium
Calcium-D-glucarate: contains 16% elemental calcium
Calcium caprylate: contains 12% elemental calcium
Calcium undecylenate: contains 10% elemental calcium
Calcium ascorbate: contains 9% elemental calcium
Calcium folinate: contains 8% elemental calcium
Calcium pantothenate: contains 8% elemental calcium
Dosing & administration
Blood pressure
Dosing & administration
>1,000 mg per day to healthy normotensive Px
Outcomes
SBP (1.14 mmHg) & DBP (0.71 mmHg), and effects were higher with intakes >1,500 mg per day (2.79 mmHg and 1.43 mmHg, respectively) (38)
Class of evidence
a
Dosing & administration
800-1,000 mg (from calcium carbonate or lactate) per day for 5-14 weeks to Px with normo- or hypertension
Outcomes
Class of evidence
b
Bone mineral density
General outcomes from A-level evidence
bone mineral density (small effect, 0.7-1.8%) within one year (i.e., no further increases observed with greater durations) in older adults and may mitigate further bone loss for up to four years, but this is unlikely to translate to clinically significant reductions in fracture risk (3.5-10%); (109)(147)(141) addition of resistance exercise may provide further benefit (101)
bone mineral density in children (1.1%), (97) with potentially greater benefits when combined with exercise (1.5-3.7%) (143)
Note: No effect of calcium supplementation was observed on BMD in lactating women (27)
Dosing & administration
1,000 mg per day over four years to postmenopausal women
Outcomes
Prevents annual bone loss observed in control groups (~1%) (109)
Class of evidence
a
Dosing & administration
400-600 mg (from calcium carbonate or citrate) 1-4 times per day for up to four years to postmenopausal women
Outcomes
Reduces bone loss and improves markers of bone resorption compared to placebo via:
total rate of bone loss per year (43%); loss in total BMD (0.4-1.1%), lumbar spine BMD (1.8-2.0%), femur BMD (0.7-1.6%), & hip BMD (2.1%)
parathyroid hormone (13-19%), osteocalcin (12-17%), undercarboxylated osteocalcin (22%), & pyridinoline (32%) (32)(92)(123)(126)(129)
Improvements in BMD may begin to attenuate after one year of use (127)
Note: Decision on dosing magnitude may depend on the Px’s baseline dietary intake of calcium to avoid excessive intake.
Class of evidence
b
Dosing & administration
500-1,000 mg (from calcium carbonate, lactogluconate-carbonate, or citrate) per day for 2-3 years in perimenopausal women
Outcomes
rate of spinal bone loss (1.2-4.8%), femoral bone loss (1%), & metacarpal cortical thickness (1%) by decreasing markers of bone turnover compared to placebo
Class of evidence
b
Dosing & administration
1,200 mg (from calcium citrate) per day over two years to healthy older men
Outcomes
Class of evidence
b
Dosing & administration
500-1,000 mg (from calcium citrate-malate, lactate gluconate, or carbonate) per day for up to seven years in adolescent girls
Outcomes
total BMD (0.73-1.3%), spine BMD (0.66-2.90%), & hip BMD (1.27%) compared to placebo
Class of evidence
b
Dosing & administration
300-1,000 mg (from calcium carbonate) per day for up to one and a half years to children with low dietary calcium intakes
Outcomes
radius BMD (4.5-7.0%) and BMC (2.5-5.5%) & lumbar BMC (4.5%)
Class of evidence
b
Cardiometabolic profile
Dosing & administration
>1,000 mg per day for minimum of 12 weeks
Outcomes
LDL-C (3.1-5.8 mg/dl) (45)
Class of evidence
a
Dosing & administration
500 mg (from calcium citrate) twice per day for one year to postmenopausal women
Outcomes
HDL-C (8%, equal to ~3.5 mg/dL) & HDL:LDL ratio
LDL-C (6%, equal to 6.12 mg/dL but borderline stat. significance)(128)
Class of evidence
b
Chronic kidney disease (CKD)
General outcomes from A-level evidence
Dosing & administration
Titrated between ~170-510 mg (from calcium acetate) based on serum phosphate three times per day for 12 weeks to Px with CKD or on hemodialysis
Outcomes
Class of evidence
b
Fractures
General outcomes from A-level evidence
relative risk of total fractures (10-11%) and vertebral fractures (14%), but not hip or forearm fractures in older adults (evidence is weak and inconsistent), (17) & osteoporotic fractures in postmenopausal women (25-75%); (42) greater efficacy may be observed in Px with low baseline dietary calcium intake, living in institutions, & with lower bodyweight. The addition of vitamin D did little to change the effect (148)
Dosing & administration
>1,200 mg per day to Px aged 50 years and older
Outcomes
relative risk of any fracture by 10% with any dose, effect was greater with >1,200 mg per day, particularly in Px with low dietary calcium intake, living in institutions, & with lower bodyweight
Note: The addition of vitamin D provided a small additional benefit. (148)
Class of evidence
a
Polycystic ovary syndrome (PCOS)
General outcomes from A-level evidence
No data currently available.
Dosing & administration
1,000 mg per day for eight weeks to overweight and obese women with PCOS and vitamin D deficiency
Outcomes
Class of evidence
b
Pregnancy outcomes and preeclampsia
General outcomes from A-level evidence
relative risk of preeclampsia by 38-62%, gestational hypertension by 9-47%, maternal death or serious morbidity by 20%, preterm birth by 12-24%, and neonatal mortality by 30%, especially in women at high risk of preeclampsia and on low calcium diets (4)(22)(24)(75)(76)(77)(80)(87)(114)(145)(149)(159)
Dosing & administration
>1,000 mg per day to pregnant women starting no later than the 34-35th week of gestation
Outcomes
relative risk of preeclampsia by 52-55%, high blood pressure by 30-35%, maternal death or serious morbidity by 20%, & preterm birth by 24%
Effects are particularly prevalent in women at high risk for preeclampsia or with low serum calcium (76)(77)
Note: Lower doses (500 mg per day) also reduced risk of preeclampsia by 62% and high blood pressure by 47%, but did not influence maternal death, serious morbidity, or preterm birth. (77)
Class of evidence
a
Dosing & administration
>1,000 mg per day to pregnant women in the 11-24th week of pregnancy
Outcomes
relative risk of gestational hypertension (9%) (4)
Class of evidence
a
Dosing & administration
600-1,200 mg per day to pregnant women starting at 20 weeks gestation to delivery
Outcomes
Note: Moderate doses (600-1,200 mg) reduced the relative risk of preeclampsia and gestational hypertension (68% and 60%), higher doses (1,200-2,000 mg) reduced risk (41% and 26%), while lower doses (<600 mg) reduced risk of preeclampsia only (57%). However, the comparative risk reduction between doses using statistical analysis was not performed. (145)
Class of evidence
a
Dosing & administration
Up to 1,000 mg per day to pregnant women
Outcomes
relative risk of preeclampsia by 64% (75)
Class of evidence
a
Dosing & administration
1,800-2,000 mg (from calcium carbonate) per day from starting between 12-25 weeks gestation to delivery to healthy pregnant women
Outcomes
relative risk of preeclampsia (56-87%), preterm birth (45-56%), & pregnancy-induced hypertension and gestational hypertension (34-72%) (10)(40)(89)(118)
Note: Supplementation during pregnancy may also reduce SBP (1.4 mmHg) and risk for high SBP (41%) in children, particularly in children with greater BMI (~5.8-6.3 mmHg & 67% risk reduction) compared to placebo. (9)
Class of evidence
b
Dosing & administration
500 mg (from calcium carbonate) three times per day starting at less than 20 weeks gestation to delivery to healthy pregnant women on low calcium diets
Outcomes
risk of eclampsia (32%), severe gestational hypertension (29%), preeclamptic complications (24%), maternal mortality (20%) and neonatal mortality (30%) (158)
Class of evidence
b
Dosing & administration
500-1,200 mg (from calcium carbonate) per day starting from less than 16 weeks gestation to delivery and up to one month postpartum to healthy pregnant women
Outcomes
Class of evidence
b
Dosing & administration
2,000 mg (from calcium carbonate) per day starting from the 20-23rd week of gestation to delivery to pregnant adolescents
Outcomes
Class of evidence
b
Premenstrual syndrome
General outcomes from A-level evidence
incidence and symptoms (5)
Dosing & administration
500 mg (from calcium carbonate) once or twice per day for two to three months to women experiencing PMS
Outcomes
Class of evidence
b
Rickets
General outcomes from A-level evidence
No data currently available.
Dosing & administration
1,000 mg (from calcium carbonate) per day for at least 24 weeks to children with nutritional rickets
Outcomes
Class of evidence
c
Thyroidectomy-induced hypocalcemia
General outcomes from A-level evidence
Dosing & administration
3,000 mg per day for two weeks post-thyroidectomy
Outcomes
risk of post-thyroidectomy hypocalcemia (46%) compared to no intervention (2)
Class of evidence
a
Type II diabetes
General outcomes from A-level evidence
No data currently available.
Dosing & administration
1,000 mg (from calcium carbonate) per day for eight weeks to Px with type II diabetes with vitamin D insufficiency
Outcomes
serum leptin (~66 ng/mL), IL-6 (5 pg/mL), & TNF-ɑ (3.2 pg/mL) compared to placebo (146)
Class of evidence
b
Dosing & administration
1,500 mg (from calcium lactate-gluconate and carbonate) per day for eight weeks to Px with type II diabetes
Outcomes
insulin sensitivity compared to control (115)
Class of evidence
c
Adverse effects
Calcium supplementation may induce gastrointestinal-related effects. Supplementation with calcium increased the relative risk of constipation, cramping, bloating, diarrhea, pain, or other symptoms by 43 to 47% compared with placebo. (94)(117)
It should be noted that controversy related to whether or not calcium supplementation increases the risk of cardiovascular events, fractures, or kidney stones exists. (12)(34)(150) Some analyses indicate that supplementation increases the risk of cardiovascular events, (15)(16)(95)(165)(167) while others do not. (7)(35)(93)(161) Similarly, an increased risk for kidney stones has been observed in some analyses, (81) but not in others. (28)(83)
Overall, supplementation with calcium may need to be more closely monitored to avoid unnecessary use in excess of recommended dietary intakes to reduce the risk of negative outcomes or adverse events. (150) In general, total daily intake of calcium (from diet and supplements) should not exceed the tolerable upper intakes levels of 2,000 to 2,500 mg per day to reduce the risk of adverse cardiovascular outcomes, (35)(88) as well as to avoid reducing the uptake of other nutrients such as iron, zinc, or phosphorus. (99)(144)
Calcium is also one of the most documented nutrients with interactions with other drugs. (156) Detailing these interactions is outside the scope of this review, but healthcare practitioners should evaluate the risks and benefits of adding calcium supplements to a treatment plan containing other pharmaceuticals.
Pharmacokinetics
Absorption
- The body can absorb up to 500 mg of calcium at a time, with very little further absorption with higher doses. (66)
- The average absorption of calcium intake is ~25%; (79) however, absorption can be highly variable (e.g., varying between 15 to 58% in healthy women). (18)
- Several factors can influence calcium absorption; estrogen deficiencies and fibre intake (reducing intestinal transit time) may reduce absorption, while increased absorption may occur with an adequate vitamin D status or when supplementation is taken with food (increasing transit time). (18)
- While adding vitamin D to improve calcium absorption is common practice, there was no better or very little improvement in calcium absorption with the addition of vitamin D in some trials. (58)(74)(105)
- The majority (95%) of calcium is absorbed in the duodenum and proximal jejunum via saturable active transport (limiting large single amounts from being absorbed). (18)
- Approximately 5% is absorbed via passive diffusion, and absorption occurs throughout the entire intestine. (18)
- Intake of calcium from dairy products, mineral waters, or supplements produce equivalent bioavailability. (14)(61)(74)(105)
Distribution
Metabolism
- In a state where serum-free calcium levels are low, reduced calcium-sensing receptor activity in the parathyroid gland stimulates secretion of parathyroid hormone (PTH).
- PTH stimulates PTH receptors in the kidney to reabsorb calcium.
- PTH stimulates 25-hydroxyvitamin D 1α hydroxylase to convert vitamin D to calcitriol, which increases intestinal calcium levels.
- PTH also stimulates resorption of calcium from bone.
- These actions ultimately increase calcium levels in the blood and provide negative feedback to reduce further parathyroid gland activity.
- In a state where serum-free calcium levels are high, increased calcium-sensing receptor activity inhibits the release of PTH (reducing the above effects) and stimulates the thyroid gland to secrete calcitonin.
- Calcitonin reduces intestinal absorption and renal reabsorption of calcium and increases calcium bone deposition, thereby reducing circulating calcium levels. (96)(142)
Excretion
- On average, 22% of calcium is lost in urine and 75% in feces, though some can be lost via the skin, hair, and sweat. (79)
- Between 100 to 250 mg of calcium can be lost in the urine, and 100 to 200 mg is excreted in the feces every day. (18)
- Estrogen deficiencies and caffeine can also increase calcium excretion. (18)
References
- Albertazzi, P., Steel, S. A., Howarth, E. M., & Purdie, D. W. (2004). Comparison of the effects of two different types of calcium supplementation on markers of bone metabolism in a postmenopausal osteopenic population with low calcium intake: A double-blind placebo-controlled trial. Climacteric: The Journal of the International Menopause Society, 7(1), 33–40. https://doi.org/10.1080/13697130310001651454
- Alhefdhi, A., Mazeh, H., & Chen, H. (2013). Role of postoperative vitamin D and/or calcium routine supplementation in preventing hypocalcemia after thyroidectomy: A systematic review and meta-analysis. The Oncologist, 18(5), 533–542. https://doi.org/10.1634/theoncologist.2012-0283
- Alvir, J. M., & Thys-Jacobs, S. (1991). Premenstrual and menstrual symptom clusters and response to calcium treatment. Psychopharmacology Bulletin, 27(2), 145–148. https://www.ncbi.nlm.nih.gov/pubmed/1924661
- An, L.-B., Li, W.-T., Xie, T.-N., Peng, X., Li, B., Xie, S.-H., Xu, J., Zhou, X.-H., & Guo, S.-N. (2015). Calcium supplementation reducing the risk of hypertensive disorders of pregnancy and related problems: A meta-analysis of multicentre randomized controlled trials. International Journal of Nursing Practice, 21(2), 19–31. https://doi.org/10.1111/ijn.12171
- Arab, A., Rafie, N., Askari, G., & Taghiabadi, M. (2020). Beneficial role of calcium in premenstrual syndrome: A systematic review of current literature. International Journal of Preventive Medicine, 11, 156. https://doi.org/10.4103/ijpvm.IJPVM_243_19
- Asemi, Z., Foroozanfard, F., Hashemi, T., Bahmani, F., Jamilian, M., & Esmaillzadeh, A. (2015). Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clinical Nutrition, 34(4), 586–592. https://doi.org/10.1016/j.clnu.2014.09.015
- Asemi, Z., Saneei, P., Sabihi, S.-S., Feizi, A., & Esmaillzadeh, A. (2015). Total, dietary, and supplemental calcium intake and mortality from all-causes, cardiovascular disease, and cancer: A meta-analysis of observational studies. Nutrition, Metabolism, and Cardiovascular Diseases, 25(7), 623–634. https://doi.org/10.1016/j.numecd.2015.03.008
- Bass, S. L., Naughton, G., Saxon, L., Iuliano-Burns, S., Daly, R., Briganti, E. M., Hume, C., & Nowson, C. (2007). Exercise and calcium combined results in a greater osteogenic effect than either factor alone: A blinded randomized placebo-controlled trial in boys. Journal of Bone and Mineral Research, 22(3), 458–464. https://doi.org/10.1359/jbmr.061201
- Belizán, J. M., Villar, J., Bergel, E., del Pino, A., Di Fulvio, S., Galliano, S. V., & Kattan, C. (1997). Long-term effect of calcium supplementation during pregnancy on the blood pressure of offspring: Follow up of a randomised controlled trial. BMJ, 315(7103), 281–285. https://doi.org/10.1136/bmj.315.7103.281
- Belizán, J. M., Villar, J., Gonzalez, L., Campodonico, L., & Bergel, E. (1991). Calcium supplementation to prevent hypertensive disorders of pregnancy. The New England Journal of Medicine, 325(20), 1399–1405. https://doi.org/10.1056/NEJM199111143252002
- Bellantone, R., Lombardi, C. P., Raffaelli, M., Boscherini, M., Alesina, P. F., De Crea, C., Traini, E., & Princi, P. (2002). Is routine supplementation therapy (calcium and vitamin D) useful after total thyroidectomy? Surgery, 132(6), 1109–1112. https://doi.org/10.1067/msy.2002.128617
- Bischoff-Ferrari, H. A., Dawson-Hughes, B., Baron, J. A., Burckhardt, P., Li, R., Spiegelman, D., Specker, B., Orav, J. E., Wong, J. B., Staehelin, H. B., O’Reilly, E., Kiel, D. P., & Willett, W. C. (2007). Calcium intake and hip fracture risk in men and women: A meta-analysis of prospective cohort studies and randomized controlled trials. The American Journal of Clinical Nutrition, 86(6), 1780–1790. https://doi.org/10.1093/ajcn/86.5.1780
- Bischoff-Ferrari, H. A., Rees, J. R., Grau, M. V., Barry, E., Gui, J., & Baron, J. A. (2008). Effect of calcium supplementation on fracture risk: A double-blind randomized controlled trial. The American Journal of Clinical Nutrition, 87(6), 1945–1951. https://doi.org/10.1093/ajcn/87.6.1945
- Bohmer, H., Müller, H., & Resch, K. L. (2000). Calcium supplementation with calcium-rich mineral waters: A systematic review and meta-analysis of its bioavailability. Osteoporosis International, 11(11), 938–943. https://doi.org/10.1007/s001980070032
- Bolland, M. J., Avenell, A., Baron, J. A., Grey, A., MacLennan, G. S., Gamble, G. D., & Reid, I. R. (2010). Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: Meta-analysis. BMJ , 341, c3691. https://doi.org/10.1136/bmj.c3691
- Bolland, M. J., Barber, P. A., Doughty, R. N., Mason, B., Horne, A., Ames, R., Gamble, G. D., Grey, A., & Reid, I. R. (2008). Vascular events in healthy older women receiving calcium supplementation: Randomised controlled trial. BMJ, 336(7638), 262–266. https://doi.org/10.1136/bmj.39440.525752.BE
- Bolland, M. J., Leung, W., Tai, V., Bastin, S., Gamble, G. D., Grey, A., & Reid, I. R. (2015). Calcium intake and risk of fracture: Systematic review. BMJ, 351, h4580. https://doi.org/10.1136/bmj.h4580
- Booth, A., & Camacho, P. (2013). A Closer look at calcium absorption and the benefits and risks of dietary versus supplemental calcium. Postgraduate Medicine, 125(6), 73–81. https://doi.org/10.3810/pgm.2013.11.2714
- Borrego, J., Pérez del Barrio, P., Serrano, P., García Cortés, M. J., Sánchez Perales, M. C., Borrego, F. J., Liébana, A., Gil Cunquero, J. M., & Pérez Bañasco, V. (2000). [A comparison of phosphorus-chelating effect of calcium carbonate versus calcium acetate before dialysis]. Nefrologia: publicacion oficial de la Sociedad Espanola Nefrologia, 20(4), 348–354. https://www.ncbi.nlm.nih.gov/pubmed/11039260
- Bristow, S. M., Gamble, G. D., Stewart, A., Horne, L., House, M. E., Aati, O., Mihov, B., Horne, A. M., & Reid, I. R. (2014). Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: A randomised controlled trial in postmenopausal women. The British Journal of Nutrition, 112(10), 1611–1620. https://doi.org/10.1017/S0007114514002785
- Broner, C. W., Stidham, G. L., Westenkirchner, D. F., & Watson, D. C. (1990). A prospective, randomized, double-blind comparison of calcium chloride and calcium gluconate therapies for hypocalcemia in critically ill children. The Journal of Pediatrics, 117(6), 986–989. https://doi.org/10.1016/s0022-3476(05)80151-9
- Brown, G., Allen, L., & Torkelson, A. (2013). Direct patient interventions that can reduce maternal mortality in developing countries: A systematic review. Family Medicine, 45(8), 550–557. https://www.ncbi.nlm.nih.gov/pubmed/24129867
- Bucher, H. C., Cook, R. J., Guyatt, G. H., Lang, J. D., Cook, D. J., Hatala, R., & Hunt, D. L. (1996). Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials. The Journal of the American Medical Association, 275(13), 1016–1022. https://doi.org/10.1001/jama.1996.03530370054031
- Bucher, H. C., Guyatt, G. H., Cook, R. J., Hatala, R., Cook, D. J., Lang, J. D., & Hunt, D. (1996). Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: A meta-analysis of randomized controlled trials. The Journal of the American Medical Association, 275(14), 1113–1117. https://doi.org/10.1001/jama.1996.03530380055031
- Buppasiri, P., Lumbiganon, P., Thinkhamrop, J., Ngamjarus, C., Laopaiboon, M., & Medley, N. (2015). Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes. Cochrane Database of Systematic Reviews, 2, CD007079. https://doi.org/10.1002/14651858.CD007079.pub3
- Burckhardt, P. (2011). Potential negative cardiovascular effects of calcium supplements [Review of Potential negative cardiovascular effects of calcium supplements]. Osteoporosis International, 22(6), 1645–1647. https://doi.org/10.1007/s00198-011-1602-5
- Cai, G., Tian, J., Winzenberg, T., & Wu, F. (2020). Calcium supplementation for improving bone density in lactating women: A systematic review and meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition, 112(1), 48–56. https://doi.org/10.1093/ajcn/nqaa103
- Candelas, G., Martinez-Lopez, J. A., Rosario, M. P., Carmona, L., & Loza, E. (2012). Calcium supplementation and kidney stone risk in osteoporosis: A systematic literature review. Clinical and Experimental Rheumatology, 30(6), 954–961. https://www.ncbi.nlm.nih.gov/pubmed/23137489
- Castelo-Branco, C., Cancelo Hidalgo, M. J., Palacios, S., Ciria-Recasens, M., Fernández-Pareja, A., Carbonell-Abella, C., Manasanch, J., & Haya-Palazuelos, J. (2020). Efficacy and safety of ossein-hydroxyapatite complex versus calcium carbonate to prevent bone loss. Climacteric: The Journal of the International Menopause Society, 23(3), 252–258. https://doi.org/10.1080/13697137.2019.1685488
- Castelo-Branco, C., Ciria-Recasens, M., Cancelo-Hidalgo, M. J., Palacios, S., Haya-Palazuelos, J., Carbonell-Abelló, J., Blanch-Rubió, J., Martínez-Zapata, M. J., Manasanch, J., & Pérez-Edo, L. (2009). Efficacy of ossein-hydroxyapatite complex compared with calcium carbonate to prevent bone loss: A meta-analysis. Menopause , 16(5), 984–991. https://doi.org/10.1097/gme.0b013e3181a1824e
- Castelo-Branco, C., Dávila, J., Alvarez, L., & Balasch, J. (2015). Comparison of the effects of calcium carbonate and ossein-hydroxyapatite complex on back and knee pain and quality of life in osteopenic perimenopausal women. Maturitas, 81(1), 76–82. https://doi.org/10.1016/j.maturitas.2015.02.265
- Chailurkit, L.-O., Saetung, S., Thakkinstian, A., Ongphiphadhanakul, B., & Rajatanavin, R. (2010). Discrepant influence of vitamin D status on parathyroid hormone and bone mass after two years of calcium supplementation. Clinical Endocrinology, 73(2), 167–172. https://doi.org/10.1111/j.1365-2265.2010.03779.x
- Chen, C., Ge, S., Li, S., Wu, L., Liu, T., & Li, C. (2017). The effects of dietary calcium supplements alone or with vitamin d on cholesterol metabolism: A meta-analysis of randomized controlled trials. The Journal of Cardiovascular Nursing, 32(5), 496–506. https://doi.org/10.1097/JCN.0000000000000379
- Chiodini, I., & Bolland, M. J. (2018). Calcium supplementation in osteoporosis: Useful or harmful? European Journal of Endocrinology, 178(4), D13–D25. https://doi.org/10.1530/EJE-18-0113
- Chung, M., Tang, A. M., Fu, Z., Wang, D. D., & Newberry, S. J. (2016). Calcium intake and cardiovascular disease risk: An updated systematic review and meta-analysis. Annals of Internal Medicine, 165(12), 856–866. https://doi.org/10.7326/M16-1165
- Ciria-Recasens, M., Blanch-Rubió, J., Coll-Batet, M., Del Pilar Lisbona-Pérez, M., Díez-Perez, A., Carbonell-Abelló, J., Manasanch, J., & Pérez-Edo, L. (2011). Comparison of the effects of ossein-hydroxyapatite complex and calcium carbonate on bone metabolism in women with senile osteoporosis: A randomized, open-label, parallel-group, controlled, prospective study. Clinical Drug Investigation, 31(12), 817–824. https://doi.org/10.1007/BF03256920
- Cormick, G., & Belizán, J. M. (2019). Calcium intake and health. Nutrients, 11(7). https://doi.org/10.3390/nu11071606
- Cormick, G., Ciapponi, A., Cafferata, M. L., & Belizán, J. M. (2015). Calcium supplementation for prevention of primary hypertension. Cochrane Database of Systematic Reviews, 6, CD010037. https://doi.org/10.1002/14651858.CD010037.pub2
- Courteix, D., Jaffré, C., Lespessailles, E., & Benhamou, L. (2005). Cumulative effects of calcium supplementation and physical activity on bone accretion in premenarchal children: A double-blind randomised placebo-controlled trial. International Journal of Sports Medicine, 26(5), 332–338. https://doi.org/10.1055/s-2004-821040
- Crowther, C. A., Hiller, J. E., Pridmore, B., Bryce, R., Duggan, P., Hague, W. M., & Robinson, J. S. (1999). Calcium supplementation in nulliparous women for the prevention of pregnancy-induced hypertension, preeclampsia and preterm birth: an Australian randomized trial. FRACOG and the ACT Study Group. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 39(1), 12–18. https://doi.org/10.1111/j.1479-828x.1999.tb03434.x
- Cullers, A., King, J. C., Van Loan, M., Gildengorin, G., & Fung, E. B. (2019). Effect of prenatal calcium supplementation on bone during pregnancy and 1 y postpartum. The American Journal of Clinical Nutrition, 109(1), 197–206. https://doi.org/10.1093/ajcn/nqy233
- Cumming, R. G., & Nevitt, M. C. (1997). Calcium for prevention of osteoporotic fractures in postmenopausal women. Journal of Bone and Mineral Research, 12(9), 1321–1329. https://doi.org/10.1359/jbmr.1997.12.9.1321
- d’Almeida Filho, E. J., da Cruz, E. A., Hoette, M., Ruzany, F., Keen, L. N., & Lugon, J. R. (2000). Calcium acetate versus calcium carbonate in the control of hyperphosphatemia in hemodialysis patients. Sao Paulo Medical Journal, 118(6), 179–184. https://doi.org/10.1590/s1516-31802000000600006
- Dawson-Hughes, B., Dallal, G. E., Krall, E. A., Sadowski, L., Sahyoun, N., & Tannenbaum, S. (1990). A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. The New England Journal of Medicine, 323(13), 878–883. https://doi.org/10.1056/NEJM199009273231305
- Derakhshandeh-Rishehri, S.-M., Ghobadi, S., Akhlaghi, M., & Faghih, S. (2020). The effect of calcium supplement intake on lipid profile: A systematic review and meta-analysis of randomized controlled clinical trials. Critical Reviews in Food Science and Nutrition, 1–10. https://doi.org/10.1080/10408398.2020.1850414
- Deroisy, R., Zartarian, M., Meurmans, L., Nelissenne, N., Micheletti, M. C., Albert, A., & Reginster, J. Y. (1997). Acute changes in serum calcium and parathyroid hormone circulating levels induced by the oral intake of five currently available calcium salts in healthy male volunteers. Clinical Rheumatology, 16(3), 249–253. https://doi.org/10.1007/BF02238959
- Dibba, B., Prentice, A., Ceesay, M., Mendy, M., Darboe, S., Stirling, D. M., Cole, T. J., & Poskitt, E. M. E. (2002). Bone mineral contents and plasma osteocalcin concentrations of Gambian children 12 and 24 mo after the withdrawal of a calcium supplement. The American Journal of Clinical Nutrition, 76(3), 681–686. https://doi.org/10.1093/ajcn/76.3.681
- Dibba, B., Prentice, A., Ceesay, M., Stirling, D. M., Cole, T. J., & Poskitt, E. M. (2000). Effect of calcium supplementation on bone mineral accretion in gambian children accustomed to a low-calcium diet. The American Journal of Clinical Nutrition, 71(2), 544–549. https://doi.org/10.1093/ajcn/71.2.544
- Dickinson, H. O., Nicolson, D. J., Cook, J. V., Campbell, F., Beyer, F. R., Ford, G. A., & Mason, J. (2006). Calcium supplementation for the management of primary hypertension in adults. Cochrane Database of Systematic Reviews, 2, CD004639. https://doi.org/10.1002/14651858.CD004639.pub2
- Edafe, O., Mech, C. E., & Balasubramanian, S. P. (2019). Calcium, vitamin D or recombinant parathyroid hormone for managing post-thyroidectomy hypoparathyroidism. Cochrane Database of Systematic Reviews, 5, CD012845. https://doi.org/10.1002/14651858.CD012845.pub2
- Elders, P. J., Lips, P., Netelenbos, J. C., van Ginkel, F. C., Khoe, E., van der Vijgh, W. J., & van der Stelt, P. F. (1994). Long-term effect of calcium supplementation on bone loss in perimenopausal women. Journal of Bone and Mineral Research, 9(7), 963–970. https://doi.org/10.1002/jbmr.5650090702
- Elders, P. J., Netelenbos, J. C., Lips, P., van Ginkel, F. C., Khoe, E., Leeuwenkamp, O. R., Hackeng, W. H., & van der Stelt, P. F. (1991). Calcium supplementation reduces vertebral bone loss in perimenopausal women: A controlled trial in 248 women between 46 and 55 years of age. The Journal of Clinical Endocrinology and Metabolism, 73(3), 533–540. https://doi.org/10.1210/jcem-73-3-533
- Emmett, M., Sirmon, M. D., Kirkpatrick, W. G., Nolan, C. R., Schmitt, G. W., & Cleveland, M. B. (1991). Calcium acetate control of serum phosphorus in hemodialysis patients. American Journal of Kidney Diseases, 17(5), 544–550. https://doi.org/10.1016/s0272-6386(12)80496-3
- Ettinger, A. S., Lamadrid-Figueroa, H., Mercado-García, A., Kordas, K., Wood, R. J., Peterson, K. E., Hu, H., Hernández-Avila, M., & Téllez-Rojo, M. M. (2014). Effect of calcium supplementation on bone resorption in pregnancy and the early postpartum: A randomized controlled trial in Mexican women. Nutrition Journal, 13(1), 116. https://doi.org/10.1186/1475-2891-13-116
- Ettinger, A. S., Lamadrid-Figueroa, H., Téllez-Rojo, M. M., Mercado-García, A., Peterson, K. E., Schwartz, J., Hu, H., & Hernández-Avila, M. (2009). Effect of calcium supplementation on blood lead levels in pregnancy: A randomized placebo-controlled trial. Environmental Health Perspectives, 117(1), 26–31. https://doi.org/10.1289/ehp.11868
- Farrerons, J., Olazabal, A., Díaz López, C., López Ciudad, A., & Rams, A. (1989). [An analysis of calcium pidolate absorption and a comparison with that of a salt in common use, gluconate-lactate-carbonate, in postmenopausal osteoporosis]. Anales de medicina interna, 6(7), 361–365. https://www.ncbi.nlm.nih.gov/pubmed/2491491
- Foroozanfard, F., Jamilian, M., Bahmani, F., Talaee, R., Talaee, N., Hashemi, T., Nasri, K., Asemi, Z., & Esmaillzadeh, A. (2015). Calcium plus vitamin D supplementation influences biomarkers of inflammation and oxidative stress in overweight and vitamin D-deficient women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial. Clinical Endocrinology, 83(6), 888–894. https://doi.org/10.1111/cen.12840
- Gallagher, J. C., Jindal, P. S., & Smith, L. M. (2014). Vitamin D does not increase calcium absorption in young women: A randomized clinical trial. Journal of Bone and Mineral Research, 29(5), 1081–1087. https://doi.org/10.1002/jbmr.2121
- Ghanbari, Z., Haghollahi, F., Shariat, M., Foroshani, A. R., & Ashrafi, M. (2009). Effects of calcium supplement therapy in women with premenstrual syndrome. Taiwanese Journal of Obstetrics & Gynecology, 48(2), 124–129. https://doi.org/10.1016/S1028-4559(09)60271-0
- Gonnelli, S., Cepollaro, C., Camporeale, A., Nardi, P., Rossi, S., & Gennari, C. (1995). Acute biochemical variations induced by two different calcium salts in healthy perimenopausal women. Calcified Tissue International, 57(3), 175–177. https://doi.org/10.1007/BF00310254
- Greupner, T., Schneider, I., & Hahn, A. (2017). Calcium bioavailability from mineral waters with different mineralization in comparison to milk and a supplement. Journal of the American College of Nutrition, 36(5), 386–390. https://doi.org/10.1080/07315724.2017.1299651
- Griffith, L. E., Guyatt, G. H., Cook, R. J., Bucher, H. C., & Cook, D. J. (1999). The influence of dietary and nondietary calcium supplementation on blood pressure: An updated metaanalysis of randomized controlled trials. American Journal of Hypertension, 12(1), 84–92. https://doi.org/10.1016/s0895-7061(98)00224-6
- Grobbee, D. E., & Hofman, A. (1986). Effect of calcium supplementation on diastolic blood pressure in young people with mild hypertension. The Lancet, 2(8509), 703–707. https://doi.org/10.1016/s0140-6736(86)90228-x
- Hansen, C., Werner, E., Erbes, H. J., Larrat, V., & Kaltwasser, J. P. (1996). Intestinal calcium absorption from different calcium preparations: Influence of anion and solubility. Osteoporosis International, 6(5), 386–393. https://doi.org/10.1007/BF01623012
- Harsløf, T., Rolighed, L., & Rejnmark, L. (2019). Huge variations in definition and reported incidence of postsurgical hypoparathyroidism: A systematic review. Endocrine, 64(1), 176–183. https://doi.org/10.1007/s12020-019-01858-4
- Harvey, J. A., Zobitz, M. M., & Pak, C. Y. (1988). Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. Journal of Bone and Mineral Research, 3(3), 253–258. https://doi.org/10.1002/jbmr.5650030303
- Heaney, R. P., Dowell, M. S., & Barger-Lux, M. J. (1999). Absorption of calcium as the carbonate and citrate salts, with some observations on method. Osteoporosis International, 9(1), 19–23. https://doi.org/10.1007/s001980050111
- Heaney, R. P., Dowell, M. S., Bierman, J., Hale, C. A., & Bendich, A. (2001). Absorbability and cost effectiveness in calcium supplementation. Journal of the American College of Nutrition, 20(3), 239–246. https://doi.org/10.1080/07315724.2001.10719038
- Heaney, R. P., Rafferty, K., Dowell, M. S., & Bierman, J. (2005). Calcium fortification systems differ in bioavailability. Journal of the American Dietetic Association, 105(5), 807–809. https://doi.org/10.1016/j.jada.2005.02.012
- Heller, H. J., Greer, L. G., Haynes, S. D., Poindexter, J. R., & Pak, C. Y. (2000). Pharmacokinetic and pharmacodynamic comparison of two calcium supplements in postmenopausal women. Journal of Clinical Pharmacology, 40(11), 1237–1244. https://www.ncbi.nlm.nih.gov/pubmed/11075309
- Heller, H. J., Stewart, A., Haynes, S., & Pak, C. Y. (1999). Pharmacokinetics of calcium absorption from two commercial calcium supplements. Journal of Clinical Pharmacology, 39(11), 1151–1154. https://www.ncbi.nlm.nih.gov/pubmed/10579145
- Hernandez-Avila, M., Gonzalez-Cossio, T., Hernandez-Avila, J. E., Romieu, I., Peterson, K. E., Aro, A., Palazuelos, E., & Hu, H. (2003). Dietary calcium supplements to lower blood lead levels in lactating women: A randomized placebo-controlled trial. Epidemiology, 14(2), 206–212. https://doi.org/10.1097/01.EDE.0000038520.66094.34
- Hervás, J. G., Prados, D., & Cerezo, S. (2003). Treatment of hyperphosphatemia with sevelamer hydrochloride in hemodialysis patients: A comparison with calcium acetate. Kidney International, 85, S69–S72. https://doi.org/10.1046/j.1523-1755.63.s85.17.x
- Hitz, M. F., Eskildsen, P. C., & Jensen, J. B. (2005). Bioavailability of calcium: comparison of calcium carbonate and milk and the effect of vitamin D, age, and sex using 24-hour urine calcium as a method. Calcified Tissue International, 77(6), 361–366. https://doi.org/10.1007/s00223-005-0299-x
- Hofmeyr, G. J., Belizán, J. M., von Dadelszen, P., & Calcium and Pre-eclampsia (CAP) Study Group. (2014). Low-dose calcium supplementation for preventing pre-eclampsia: A systematic review and commentary. An International Journal of Obstetrics and Gynaecology, 121(8), 951–957. https://doi.org/10.1111/1471-0528.12613
- Hofmeyr, G. J., Duley, L., & Atallah, A. (2007). Dietary calcium supplementation for prevention of pre-eclampsia and related problems: A systematic review and commentary. An International Journal of Obstetrics and Gynaecology, 114(8), 933–943. https://doi.org/10.1111/j.1471-0528.2007.01389.x
- Hofmeyr, G. J., Lawrie, T. A., Atallah, Á. N., & Torloni, M. R. (2018). Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database of Systematic Reviews, 10, CD001059. https://doi.org/10.1002/14651858.CD001059.pub5
- Hu, Z.-C., Tang, Q., Sang, C.-M., Tang, L., Li, X., Zheng, G., Feng, Z.-H., Xuan, J.-W., Shen, Z.-H., Shen, L.-Y., Ni, W.-F., & Wu, A.-M. (2019). Comparison of fracture risk using different supplemental doses of vitamin D, calcium or their combination: A network meta-analysis of randomised controlled trials. BMJ Open, 9(10), e024595. https://doi.org/10.1136/bmjopen-2018-024595
- Hunt, C. D., & Johnson, L. K. (2007). Calcium requirements: New estimations for men and women by cross-sectional statistical analyses of calcium balance data from metabolic studies. The American Journal of Clinical Nutrition, 86(4), 1054–1063. https://doi.org/10.1093/ajcn/86.4.1054
- Imdad, A., Jabeen, A., & Bhutta, Z. A. (2011). Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: A meta-analysis of studies from developing countries. BMC Public Health, 11(3), S18. https://doi.org/10.1186/1471-2458-11-S3-S18
- Jackson, R. D., LaCroix, A. Z., Gass, M., Wallace, R. B., Robbins, J., Lewis, C. E., Bassford, T., Beresford, S. A. A., Black, H. R., Blanchette, P., Bonds, D. E., Brunner, R. L., Brzyski, R. G., Caan, B., Cauley, J. A., Chlebowski, R. T., Cummings, S. R., Granek, I., Hays, J., … Women’s Health Initiative Investigators. (2006). Calcium plus vitamin D supplementation and the risk of fractures. The New England Journal of Medicine, 354(7), 669–683. https://doi.org/10.1056/NEJMoa055218
- Jamal, S. A., Vandermeer, B., Raggi, P., Mendelssohn, D. C., Chatterley, T., Dorgan, M., Lok, C. E., Fitchett, D., & Tsuyuki, R. T. (2013). Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: An updated systematic review and meta-analysis. The Lancet, 382(9900), 1268–1277. https://doi.org/10.1016/S0140-6736(13)60897-1
- Kahwati, L. C., Weber, R. P., Pan, H., Gourlay, M., LeBlanc, E., Coker-Schwimmer, M., & Viswanathan, M. (2018). Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: Evidence report and systematic review for the US preventive services task force. The Journal of the American Medical Association, 319(15), 1600–1612. https://doi.org/10.1001/jama.2017.21640
- Kalluru, R., Ames, R., Mason, B., Bolland, M. J., Gamble, G. D., Grey, A., Horne, A., & Reid, I. R. (2015). Bone density in healthy men after cessation of calcium supplements: 20-month follow-up of a randomized controlled trial. Osteoporosis International, 26(1), 173–178. https://doi.org/10.1007/s00198-014-2896-x
- Karp, H. J., Ketola, M. E., & Lamberg-Allardt, C. J. E. (2009). Acute effects of calcium carbonate, calcium citrate and potassium citrate on markers of calcium and bone metabolism in young women. The British Journal of Nutrition, 102(9), 1341–1347. https://doi.org/10.1017/S0007114509990195
- Kenny, A. M., Prestwood, K. M., Biskup, B., Robbins, B., Zayas, E., Kleppinger, A., Burleson, J. A., & Raisz, L. G. (2004). Comparison of the effects of calcium loading with calcium citrate or calcium carbonate on bone turnover in postmenopausal women. Osteoporosis International, 15(4), 290–294. https://doi.org/10.1007/s00198-003-1567-0
- Khaing, W., Vallibhakara, S. A.-O., Tantrakul, V., Vallibhakara, O., Rattanasiri, S., McEvoy, M., Attia, J., & Thakkinstian, A. (2017). Calcium and vitamin D supplementation for prevention of preeclampsia: A systematic review and network meta-analysis. Nutrients, 9(10). https://doi.org/10.3390/nu9101141
- Kopecky, S. L., Bauer, D. C., Gulati, M., Nieves, J. W., Singer, A. J., Toth, P. P., Underberg, J. A., Wallace, T. C., & Weaver, C. M. (2016). Lack of evidence linking calcium with or without vitamin d supplementation to cardiovascular disease in generally healthy adults: A clinical guideline from the national osteoporosis foundation and the American society for preventive cardiology. Annals of Internal Medicine, 165(12), 867–868. https://doi.org/10.7326/M16-1743
- Kumar, A., Devi, S. G., Batra, S., Singh, C., & Shukla, D. K. (2009). Calcium supplementation for the prevention of pre-eclampsia. International Journal of Gynaecology and Obstetrics, 104(1), 32–36. https://doi.org/10.1016/j.ijgo.2008.08.027
- Lee, W. T., Leung, S. S., Leung, D. M., Tsang, H. S., Lau, J., & Cheng, J. C. (1995). A randomized double-blind controlled calcium supplementation trial, and bone and height acquisition in children. The British Journal of Nutrition, 74(1), 125–139. https://doi.org/10.1079/bjn19950112
- Lee, W. T., Leung, S. S., Wang, S. H., Xu, Y. C., Zeng, W. P., Lau, J., Oppenheimer, S. J., & Cheng, J. C. (1994). Double-blind, controlled calcium supplementation and bone mineral accretion in children accustomed to a low-calcium diet. The American Journal of Clinical Nutrition, 60(5), 744–750. https://doi.org/10.1093/ajcn/60.5.744
- Lewis, J. R., Brennan-Speranza, T. C., Levinger, I., Byrnes, E., Lim, E. M., Blekkenhorst, L. C., Sim, M., Hodgson, J. M., Zhu, K., Lim, W. H., Adams, L. A., & Prince, R. L. (2019). Effects of calcium supplementation on circulating osteocalcin and glycated haemoglobin in older women. Osteoporosis International, 30(10), 2065–2072. https://doi.org/10.1007/s00198-019-05087-3
- Lewis, J. R., Radavelli-Bagatini, S., Rejnmark, L., Chen, J. S., Simpson, J. M., Lappe, J. M., Mosekilde, L., Prentice, R. L., & Prince, R. L. (2015). The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: A collaborative meta-analysis of randomized controlled trials. Journal of Bone and Mineral Research, 30(1), 165–175. https://doi.org/10.1002/jbmr.2311
- Lewis, J. R., Zhu, K., & Prince, R. L. (2012). Adverse events from calcium supplementation: relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation. Journal of Bone and Mineral Research, 27(3), 719–722. https://doi.org/10.1002/jbmr.1484
- Li, K., Kaaks, R., Linseisen, J., & Rohrmann, S. (2012). Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPIC-Heidelberg). Heart, 98(12), 920–925. https://doi.org/10.1136/heartjnl-2011-301345
- Li, K., Wang, X.-F., Li, D.-Y., Chen, Y.-C., Zhao, L.-J., Liu, X.-G., Guo, Y.-F., Shen, J., Lin, X., Deng, J., Zhou, R., & Deng, H.-W. (2018). The good, the bad, and the ugly of calcium supplementation: A review of calcium intake on human health. Clinical Interventions in Aging, 13, 2443–2452. https://doi.org/10.2147/CIA.S157523
- Li N., Wang Y., & Yin S.-A. (2007). [Evaluation of milk intake and calcium supplement on bone mineral density and growth in children through Meta-analysis]. Chinese Journal of Preventive Medicine, 41(3), 172–175. https://www.ncbi.nlm.nih.gov/pubmed/17708864
- Lloyd, T., Andon, M. B., Rollings, N., Martel, J. K., Landis, J. R., Demers, L. M., Eggli, D. F., Kieselhorst, K., & Kulin, H. E. (1993). Calcium supplementation and bone mineral density in adolescent girls. The Journal of the American Medical Association, 270(7), 841–844. https://www.ncbi.nlm.nih.gov/pubmed/8340983
- Lönnerdal, B. (2010). Calcium and iron absorption–mechanisms and public health relevance. International Journal for Vitamin and Nutrition Research, 80(4-5), 293–299. https://doi.org/10.1024/0300-9831/a000036
- López-Jaramillo, P., Delgado, F., Jácome, P., Terán, E., Ruano, C., & Rivera, J. (1997). Calcium supplementation and the risk of preeclampsia in Ecuadorian pregnant teenagers. Obstetrics and Gynecology, 90(2), 162–167. https://doi.org/10.1016/S0029-7844(97)00254-8
- Martyn-St James, M., & Carroll, S. (2006). High-intensity resistance training and postmenopausal bone loss: A meta-analysis. Osteoporosis International, 17(8), 1225–1240. https://doi.org/10.1007/s00198-006-0083-4
- Matkovic, V., Goel, P. K., Badenhop-Stevens, N. E., Landoll, J. D., Li, B., Ilich, J. Z., Skugor, M., Nagode, L. A., Mobley, S. L., Ha, E.-J., Hangartner, T. N., & Clairmont, A. (2005). Calcium supplementation and bone mineral density in females from childhood to young adulthood: A randomized controlled trial. The American Journal of Clinical Nutrition, 81(1), 175–188. https://doi.org/10.1093/ajcn/81.1.175
- Miller, J. Z., Smith, D. L., Flora, L., Slemenda, C., Jiang, X. Y., & Johnston, C. C., Jr. (1988). Calcium absorption from calcium carbonate and a new form of calcium (CCM) in healthy male and female adolescents. The American Journal of Clinical Nutrition, 48(5), 1291–1294. https://doi.org/10.1093/ajcn/48.5.1291
- Mølgaard, C., Thomsen, B. L., & Michaelsen, K. F. (2004). Effect of habitual dietary calcium intake on calcium supplementation in 12-14-y-old girls. The American Journal of Clinical Nutrition, 80(5), 1422–1427. https://doi.org/10.1093/ajcn/80.5.1422
- Mortensen, L., & Charles, P. (1996). Bioavailability of calcium supplements and the effect of Vitamin D: Comparisons between milk, calcium carbonate, and calcium carbonate plus vitamin D. The American Journal of Clinical Nutrition, 63(3), 354–357. https://doi.org/10.1093/ajcn/63.3.354
- Nakamura, K., Saito, T., Kobayashi, R., Oshiki, R., Kitamura, K., Oyama, M., Narisawa, S., Nashimoto, M., Takahashi, S., & Takachi, R. (2012). Effect of low-dose calcium supplements on bone loss in perimenopausal and postmenopausal Asian women: A randomized controlled trial. Journal of Bone and Mineral Research, 27(11), 2264–2270. https://doi.org/10.1002/jbmr.1676
- Nakamura, K., Saito, T., Kobayashi, R., Oshiki, R., Kitamura, K., & Watanabe, Y. (2019). Physical activity modifies the effect of calcium supplements on bone loss in perimenopausal and postmenopausal women: Subgroup analysis of a randomized controlled trial. Archives of Osteoporosis, 14(1), 17. https://doi.org/10.1007/s11657-019-0575-4
- National Institutes of Health. (2020, March 26). Calcium: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Calcium-HealthProfessional/
- Nordin, B. E. C. (2009). The effect of calcium supplementation on bone loss in 32 controlled trials in postmenopausal women. Osteoporosis International, 20(12), 2135–2143. https://doi.org/10.1007/s00198-009-0926-x
- Nowak, M. G., Szulc-Musioł, B., & Ryszka, F. (2008). Pharmacokinetics of calcium from calcium supplements in healthy volunteers. Pakistan Journal of Pharmaceutical Sciences, 21(2), 109–112. https://www.ncbi.nlm.nih.gov/pubmed/18390439
- Nowson, C. A., Green, R. M., Hopper, J. L., Sherwin, A. J., Young, D., Kaymakci, B., Guest, C. S., Smid, M., Larkins, R. G., & Wark, J. D. (1997). A co-twin study of the effect of calcium supplementation on bone density during adolescence. Osteoporosis International, 7(3), 219–225. https://doi.org/10.1007/BF01622292
- Oliván Martínez, J., Pérez Cano, R., Miranda García, M. J., Montoya García, M. J., Moruno García, R., Cuenca López, L., & Garrido Peralta, M. (1989). [Effect of an oral calcium supplement in the treatment of slight-to- moderate essential arterial hypertension]. Anales de medicina interna, 6(4), 192–196. https://www.ncbi.nlm.nih.gov/pubmed/2491521
- Pan Z., Zhao L., Guo D., Yang R., Xu C., & Wu X. (2000). [Effects of oral calcium supplementation on blood pressure in population]. Chinese Journal of Preventive Medicine, 34(2), 109–112. https://www.ncbi.nlm.nih.gov/pubmed/11860914
- Park, J. J. H., Harari, O., Siden, E., Zoratti, M., Dron, L., Zannat, N.-E., Lester, R. T., Thorlund, K., & Mills, E. J. (2019). Interventions to improve birth outcomes of pregnant women living in low- and middle-income countries: a systematic review and network meta-analysis. Gates Open Research, 3, 1657. https://doi.org/10.12688/gatesopenres.13081.2
- Pikilidou, M. I., Lasaridis, A. N., Sarafidis, P. A., Befani, C. D., Koliakos, G. G., Tziolas, I. M., Kazakos, K. A., Yovos, J. G., & Nilsson, P. M. (2009). Insulin sensitivity increase after calcium supplementation and change in intraplatelet calcium and sodium-hydrogen exchange in hypertensive patients with Type 2 diabetes. Diabetic Medicine, 26(3), 211–219. https://doi.org/10.1111/j.1464-5491.2009.02673.x
- Praet, J. P., Peretz, A., Mets, T., & Rozenberg, S. (1998). Comparative study of the intestinal absorption of three salts of calcium in young and elderly women. Journal of Endocrinological Investigation, 21(4), 263–267. https://doi.org/10.1007/BF03347313
- Prince, R. L., Devine, A., Dhaliwal, S. S., & Dick, I. M. (2006). Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Archives of Internal Medicine, 166(8), 869–875. https://doi.org/10.1001/archinte.166.8.869
- Purwar, M., Kulkarni, H., Motghare, V., & Dhole, S. (1996). Calcium supplementation and prevention of pregnancy induced hypertension. The Journal of Obstetrics and Gynaecology Research, 22(5), 425–430. https://doi.org/10.1111/j.1447-0756.1996.tb01052.x
- Qunibi, W., Moustafa, M., Muenz, L. R., He, D. Y., Kessler, P. D., Diaz-Buxo, J. A., Budoff, M., & CARE-2 Investigators. (2008). A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) study. American Journal of Kidney Diseases, 51(6), 952–965. https://doi.org/10.1053/j.ajkd.2008.02.298
- Qunibi, W., Winkelmayer, W. C., Solomon, R., Moustafa, M., Kessler, P., Ho, C.-H., Greenberg, J., & Diaz-Buxo, J. A. (2011). A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease. BMC Nephrology, 12, 9. https://doi.org/10.1186/1471-2369-12-9
- Qunibi, W. Y., Hootkins, R. E., McDowell, L. L., Meyer, M. S., Simon, M., Garza, R. O., Pelham, R. W., Cleveland, M. V. B., Muenz, L. R., He, D. Y., & Nolan, C. R. (2004). Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study). Kidney International, 65(5), 1914–1926. https://doi.org/10.1111/j.1523-1755.2004.00590.x
- Radakrishnan, A., Reddy, A. T., Dalal, P., Rastatter, J. C., Josefson, J. L., Samis, J. H., Beestrum, M., Tian, Y., & Raval, M. V. (2021). Hypocalcemia prevention and management after thyroidectomy in children: A systematic review. Journal of Pediatric Surgery, 56(3), 526–533. https://doi.org/10.1016/j.jpedsurg.2020.08.032
- Rajatanavin, R., Chailurkit, L., Saetung, S., Thakkinstian, A., & Nimitphong, H. (2013). The efficacy of calcium supplementation alone in elderly Thai women over a 2-year period: a randomized controlled trial. Osteoporosis International, 24(11), 2871–2877. https://doi.org/10.1007/s00198-013-2387-5
- Reginster, J. Y., Denis, D., Bartsch, V., Deroisy, R., Zegels, B., & Franchimont, P. (1993). Acute biochemical variations induced by four different calcium salts in healthy male volunteers. Osteoporosis International, 3(5), 271–275. https://doi.org/10.1007/BF01623832
- Reid, I. R., Ames, R., Mason, B., Reid, H. E., Bacon, C. J., Bolland, M. J., Gamble, G. D., Grey, A., & Horne, A. (2008). Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Archives of Internal Medicine, 168(20), 2276–2282. https://doi.org/10.1001/archinte.168.20.2276
- Reid, I. R., Ames, R. W., Evans, M. C., Gamble, G. D., & Sharpe, S. J. (1993). Effect of calcium supplementation on bone loss in postmenopausal women. The New England Journal of Medicine, 328(7), 460–464. https://doi.org/10.1056/NEJM199302183280702
- Reid, I. R., Ames, R. W., Evans, M. C., Gamble, G. D., & Sharpe, S. J. (1995). Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: A randomized controlled trial. The American Journal of Medicine, 98(4), 331–335. https://doi.org/10.1016/S0002-9343(99)80310-6
- Reid, I. R., Mason, B., Horne, A., Ames, R., Clearwater, J., Bava, U., Orr-Walker, B., Wu, F., Evans, M. C., & Gamble, G. D. (2002). Effects of calcium supplementation on serum lipid concentrations in normal older women: A randomized controlled trial. The American Journal of Medicine, 112(5), 343–347. https://doi.org/10.1016/s0002-9343(01)01138-x
- Riggs, B. L., O’Fallon, W. M., Muhs, J., O’Connor, M. K., Kumar, R., & Melton, L. J., 3rd. (1998). Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. Journal of Bone and Mineral Research, 13(2), 168–174. https://doi.org/10.1359/jbmr.1998.13.2.168
- Roh, J.-L., Park, J.-Y., & Park, C. I. (2009). Prevention of postoperative hypocalcemia with routine oral calcium and vitamin D supplements in patients with differentiated papillary thyroid carcinoma undergoing total thyroidectomy plus central neck dissection. Cancer, 115(2), 251–258. https://doi.org/10.1002/cncr.24027
- Rozen, G. S., Rennert, G., Dodiuk-Gad, R. P., Rennert, H. S., Ish-Shalom, N., Diab, G., Raz, B., & Ish-Shalom, S. (2003). Calcium supplementation provides an extended window of opportunity for bone mass accretion after menarche. The American Journal of Clinical Nutrition, 78(5), 993–998. https://doi.org/10.1093/ajcn/78.5.993
- Ruospo, M., Palmer, S. C., Natale, P., Craig, J. C., Vecchio, M., Elder, G. J., & Strippoli, G. F. (2018). Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD). Cochrane Database of Systematic Reviews, 8, CD006023. https://doi.org/10.1002/14651858.CD006023.pub3
- Sakhaee, K., Bhuket, T., Adams-Huet, B., & Rao, D. S. (1999). Meta-analysis of calcium bioavailability: A comparison of calcium citrate with calcium carbonate. American Journal of Therapeutics, 6(6), 313–321. https://doi.org/10.1097/00045391-199911000-00005
- Samieipour, S., Kiani, F., Pour, Y. S., Heydarabadi, A. B., & Zade, R. R. (2016). Comparing the effects of vitamin b1 and calcium on premenstrual syndrome (PMS) among female students, Ilam-Iran. International Journal of Pediatrics, 4(9), 3517–3526. https://doi.org/10.22038/ijp.2016.7345
- Samozai, M. N., & Kulkarni, A. K. (2015). Do calcium supplements increase serum and urine calcium levels in post-menopausal women? The Journal of Nutrition, Health & Aging, 19(5), 537–541. https://doi.org/10.1007/s12603-014-0532-2
- Sekercioglu, N., Angeliki Veroniki, A., Thabane, L., Busse, J. W., Akhtar-Danesh, N., Iorio, A., Cruz Lopes, L., & Guyatt, G. H. (2017). Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: A systematic review and NMA. PloS One, 12(3), e0171028. https://doi.org/10.1371/journal.pone.0171028
- Sekercioglu, N., Thabane, L., Díaz Martínez, J. P., Nesrallah, G., Longo, C. J., Busse, J. W., Akhtar-Danesh, N., Agarwal, A., Al-Khalifah, R., Iorio, A., & Guyatt, G. H. (2016). Comparative effectiveness of phosphate binders in patients with chronic kidney disease: A systematic review and network meta-analysis. PloS One, 11(6), e0156891. https://doi.org/10.1371/journal.pone.0156891
- Shankar, K., M, S., Raizada, P., & Jain, R. (2018). A randomized open-label clinical study comparing the efficacy, safety, and bioavailability of calcium lysinate with calcium carbonate and calcium citrate malate in osteopenia patients. Journal of Orthopaedic Case Reports, 8(4), 15–19. https://pubmed.ncbi.nlm.nih.gov/30687654/
- Sheikh, M. S., Santa Ana, C. A., Nicar, M. J., Schiller, L. R., & Fordtran, J. S. (1987). Gastrointestinal absorption of calcium from milk and calcium salts. The New England Journal of Medicine, 317(9), 532–536. https://doi.org/10.1056/NEJM198708273170903
- Shobeiri, F., Araste, F. E., Ebrahimi, R., Jenabi, E., & Nazari, M. (2017). Effect of calcium on premenstrual syndrome: A double-blind randomized clinical trial. Obstetrics & Gynecology Science, 60(1), 100–105. https://doi.org/10.5468/ogs.2017.60.1.100
- Silk, L. N., Greene, D. A., & Baker, M. K. (2015). The effect of calcium or calcium and vitamin d supplementation on bone mineral density in healthy males: A systematic review and meta-analysis. International Journal of Sport Nutrition and Exercise Metabolism, 25(5), 510–524. https://doi.org/10.1123/ijsnem.2014-0202
- Song, L. (2017). Calcium and bone metabolism indices. Advances in Clinical Chemistry, 82, 1–46. https://doi.org/10.1016/bs.acc.2017.06.005
- Specker, B., Thiex, N. W., & Sudhagoni, R. G. (2015). Does exercise influence pediatric bone? A systematic review. Clinical Orthopaedics and Related Research, 473(11), 3658–3672. https://doi.org/10.1007/s11999-015-4467-7
- Straub, D. A. (2007). Calcium supplementation in clinical practice: A review of forms, doses, and indications. Nutrition in Clinical Practice, 22(3), 286–296. https://doi.org/10.1177/0115426507022003286
- Sun, X., Li, H., He, X., Li, M., Yan, P., Xun, Y., Lu, C., Yang, K., & Zhang, X. (2019). The association between calcium supplement and preeclampsia and gestational hypertension: A systematic review and meta-analysis of randomized trials. Hypertension in Pregnancy, 38(2), 129–139. https://doi.org/10.1080/10641955.2019.1593445
- Tabesh, M., Azadbakht, L., Faghihimani, E., Tabesh, M., & Esmaillzadeh, A. (2014). Calcium-vitamin D cosupplementation influences circulating inflammatory biomarkers and adipocytokines in vitamin D-insufficient diabetics: A randomized controlled clinical trial. The Journal of Clinical Endocrinology and Metabolism, 99(12), E2485–E2493. https://doi.org/10.1210/jc.2014-1977
- Tai, V., Leung, W., Grey, A., Reid, I. R., & Bolland, M. J. (2015). Calcium intake and bone mineral density: Systematic review and meta-analysis. BMJ , 351, h4183. https://doi.org/10.1136/bmj.h4183
- Tang, B. M. P., Eslick, G. D., Nowson, C., Smith, C., & Bensoussan, A. (2007). Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: A meta-analysis. The Lancet, 370(9588), 657–666. https://doi.org/10.1016/S0140-6736(07)61342-7
- Tang, R., Tang, I. C., Henry, A., & Welsh, A. (2015). Limited evidence for calcium supplementation in preeclampsia prevention: A meta-analysis and systematic review. Hypertension in Pregnancy, 34(2), 181–203. https://doi.org/10.3109/10641955.2014.988353
- Tankeu, A. T., Ndip Agbor, V., & Noubiap, J. J. (2017). Calcium supplementation and cardiovascular risk: A rising concern. Journal of Clinical Hypertension, 19(6), 640–646. https://doi.org/10.1111/jch.13010
- Thacher, T. D., Fischer, P. R., Pettifor, J. M., Lawson, J. O., Isichei, C. O., Reading, J. C., & Chan, G. M. (1999). A comparison of calcium, vitamin D, or both for nutritional rickets in Nigerian children. The New England Journal of Medicine, 341(8), 563–568. https://doi.org/10.1056/NEJM199908193410803
- Thacher, T. D., Smith, L., Fischer, P. R., Isichei, C. O., Cha, S. S., & Pettifor, J. M. (2016). Optimal dose of calcium for treatment of nutritional rickets: A randomized controlled trial. Journal of Bone and Mineral Research, 31(11), 2024–2031. https://doi.org/10.1002/jbmr.2886
- Thys-Jacobs, S., Ceccarelli, S., Bierman, A., Weisman, H., Cohen, M. A., & Alvir, J. (1989). Calcium supplementation in premenstrual syndrome: A randomized crossover trial. Journal of General Internal Medicine, 4(3), 183–189. https://doi.org/10.1007/BF02599520
- Thys-Jacobs, S., Starkey, P., Bernstein, D., & Tian, J. (1998). Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. American Journal of Obstetrics and Gynecology, 179(2), 444–452. https://doi.org/10.1016/s0002-9378(98)70377-1
- Tondapu, P., Provost, D., Adams-Huet, B., Sims, T., Chang, C., & Sakhaee, K. (2009). Comparison of the absorption of calcium carbonate and calcium citrate after Roux-en-Y gastric bypass. Obesity Surgery, 19(9), 1256–1261. https://doi.org/10.1007/s11695-009-9850-6
- Tsai, H.-H., Lin, H.-W., Simon Pickard, A., Tsai, H.-Y., & Mahady, G. B. (2012). Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: A systematic literature review. International Journal of Clinical Practice, 66(11), 1056–1078. https://doi.org/10.1111/j.1742-1241.2012.03008.x
- van Mierlo, L. A. J., Arends, L. R., Streppel, M. T., Zeegers, M. P. A., Kok, F. J., Grobbee, D. E., & Geleijnse, J. M. (2006). Blood pressure response to calcium supplementation: A meta-analysis of randomized controlled trials. Journal of Human Hypertension, 20(8), 571–580. https://doi.org/10.1038/sj.jhh.1002038
- Villar, J., Abdel-Aleem, H., Merialdi, M., Mathai, M., Ali, M. M., Zavaleta, N., Purwar, M., Hofmeyr, J., Nguyen, T. N. N., Campódonico, L., Landoulsi, S., Carroli, G., Lindheimer, M., & World Health Organization Calcium Supplementation for the Prevention of Preeclampsia Trial Group. (2006). World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. American Journal of Obstetrics and Gynecology, 194(3), 639–649. https://doi.org/10.1016/j.ajog.2006.01.068
- Villar, J., & Belizán, J. M. (2000). Same nutrient, different hypotheses: Disparities in trials of calcium supplementation during pregnancy. The American Journal of Clinical Nutrition, 71(5), 1375S – 9S. https://www.ncbi.nlm.nih.gov/pubmed/10799416
- Villar, J., & Repke, J. T. (1990). Calcium supplementation during pregnancy may reduce preterm delivery in high-risk populations. American Journal of Obstetrics and Gynecology, 163(4 Pt 1), 1124–1131. https://doi.org/10.1016/0002-9378(90)90669-x
- Wang, L., Manson, J. E., Song, Y., & Sesso, H. D. (2010). Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Annals of Internal Medicine, 152(5), 315–323. https://doi.org/10.7326/0003-4819-152-5-201003020-00010
- Wang, Y., Xie, G., Huang, Y., Zhang, H., Yang, B., & Mao, Z. (2015). Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: A meta-analysis. PloS One, 10(3), e0121376. https://doi.org/10.1371/journal.pone.0121376
- Wasilewski, G. B., Vervloet, M. G., & Schurgers, L. J. (2019). The bone-vasculature axis: Calcium supplementation and the role of vitamin K. Frontiers in Cardiovascular Medicine, 6, 6. https://doi.org/10.3389/fcvm.2019.00006
- Wiria, M., Tran, H. M., Nguyen, P. H. B., Valencia, O., Dutta, S., & Pouteau, E. (2020). Relative bioavailability and pharmacokinetic comparison of calcium glucoheptonate with calcium carbonate. Pharmacology Research & Perspectives, 8(2), e00589. https://doi.org/10.1002/prp2.589
- Xiao, Q., Murphy, R. A., Houston, D. K., Harris, T. B., Chow, W.-H., & Park, Y. (2013). Dietary and supplemental calcium intake and cardiovascular disease mortality: The National Institutes of Health-AARP diet and health study. JAMA Internal Medicine, 173(8), 639–646. https://doi.org/10.1001/jamainternmed.2013.3283
- Xing, T., Hu, Y., Wang, B., & Zhu, J. (2019). Role of oral calcium supplementation alone or with vitamin D in preventing post-thyroidectomy hypocalcaemia: A meta-analysis. Medicine, 98(8), e14455. https://doi.org/10.1097/MD.0000000000014455
- Yang, C., Shi, X., Xia, H., Yang, X., Liu, H., Pan, D., & Sun, G. (2020). The evidence and controversy between dietary calcium intake and calcium supplementation and the risk of cardiovascular disease: A systematic review and meta-analysis of cohort studies and randomized controlled trials. Journal of the American College of Nutrition, 39(4), 352–370. https://doi.org/10.1080/07315724.2019.1649219
- Zhao, J.-G., Zeng, X.-T., Wang, J., & Liu, L. (2017). Association between calcium or vitamin d supplementation and fracture incidence in community-dwelling older adults: a systematic review and meta-analysis. The Journal of the American Medical Association, 318(24), 2466–2482. https://doi.org/10.1001/jama.2017.19344
- Zhou, C., Fan, S., Zhou, L., Ni, Y., Huang, T., & Shi, Y. (1994). Clinical observation of treatment of hypertension with calcium. American Journal of Hypertension, 7(4), 363–367. https://doi.org/10.1093/ajh/7.4.363